Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD) Academic Article uri icon

Overview

MeSH Major

  • Azithromycin
  • Pulmonary Disease, Chronic Obstructive

abstract

  • We found no evidence that beta-blocker use was unsafe or associated with worse pulmonary outcomes in study participants with moderate to severe COPD.

publication date

  • June 19, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5477165

Digital Object Identifier (DOI)

  • 10.1186/s12931-017-0609-7

PubMed ID

  • 28629419

Additional Document Info

start page

  • 124

volume

  • 18

number

  • 1